Test Stability with Secondary Packaging to Reflect Real-World Exposure

Understanding the Tip:

Why secondary packaging matters in stability testing:

Secondary packaging—such as cartons, sleeves, or outer boxes—serves a critical role in protecting pharmaceutical products from light, mechanical stress, and environmental exposure. However, many stability protocols focus only on primary packaging (e.g., blister, bottle, vial), overlooking the protective role of outer packaging. Testing samples in their full market-ready configuration helps assess the influence of the complete packaging system on long-term product integrity.

Consequences of excluding secondary packaging from testing:

Without full packaging simulation:

Light-sensitive products may degrade faster than anticipated
Labels, ink, or protective coatings may not be evaluated for durability
Actual shelf-life performance in market settings may differ from test conditions
Regulatory reviewers may question whether real-world protection was reflected

Incorporating secondary packaging into your stability study ensures that your shelf-life data reflects reality—not just theory.

Regulatory and Technical Context:

ICH, WHO, and GMP requirements:

ICH Q1A(R2) advises testing “as marketed” configurations where relevant, and ICH Q1B (Photostability) clearly mandates light exposure testing with and without packaging. WHO TRS 1010 also supports the inclusion of secondary packaging where it contributes to product protection. CTD Module 3.2.P.7 should describe the container-closure system—including secondary elements—and justify its role in the stability profile.

Inspection and submission considerations:

Auditors may ask:

Whether the marketed pack configuration was used

during testing

If outer packaging was tested for photostability or mechanical durability

What protective function the carton or sleeve provides (e.g., light barrier, humidity protection)

Inadequate consideration of packaging layers may delay approvals or trigger additional data requests.

Best Practices and Implementation:

Include complete market-ready units in your test matrix:

Stability chambers should contain:

Samples with full outer packaging (e.g., bottle in carton, blister in carton)
Secondary packs sealed or folded as in market presentation
Inserts or product leaflets if relevant to barrier function

This ensures simulation of heat, light, and humidity exposure as per actual storage and distribution environments.

Evaluate light, mechanical, and ink stability under real packaging:

Test for:

Photostability of the product through outer packaging (per ICH Q1B)
Fading, ink bleeding, or adhesive weakening on cartons
Carton structural integrity over time under humidity/temperature conditions

Use control samples without secondary packaging to assess comparative impact and protection offered.

Document secondary packaging in protocols and reports:

Include in:

Stability protocol design and rationale
Packaging justification in CTD Module 3.2.P.2 and P.7
Summary of results in 3.2.P.8.3 with observations on outer package condition

Ensure marketing pack designs used in stability are consistent with commercial configurations submitted to regulatory authorities.

Secondary packaging is not merely an aesthetic or logistical component—it plays a protective role that can significantly influence pharmaceutical stability. Including it in your testing protocol ensures that shelf-life determinations are accurate, realistic, and compliant with global regulatory expectations.